Sign in
CRMD Stock Price, Chart, Stats & News
CorMedix Inc.
Save
CorMedix Inc. (CRMD) does not currently pay a dividend.
642.52M
Market cap
4.33x
Current P/E
16.50x
Forward P/E
CRMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 88.46% |
Operating margin | 48.17% |
Pretax margin | 48.13% |
Net margin | 52.31% |
Effective tax rate | -8.69% |
ROA | 19.74% |
ROE | 58.50% |
D/E | 0.37x |
Interest coverage ratio | 53.97x |
CRMD valuation
P/E | 4.33x |
P/S | 1.70x |
P/B | 1.31x |
P/CF | 3.02x |
P/FCF | 3.04x |
P/OCF | 3.02x |
PEG | -1.83x |
EV multiple | 3.19x |
About
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care.
Similar securities
Based on sector and market capitalization
Report issue